ASAM Provider Guide

National Practice Guideline

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1019954

Contents of this Issue

Navigation

Page 13 of 23

12 Treatment Figure 1. Evaluation and Treatment Physical History • Concomitant medical conditions (hepatitis, HIV, TB, acute trauma, pregnancy) • Other substance use including tobacco • Offer hepatitis B vaccine (?) • Offer contraception (?) • Withdrawal management (WM) Mental Health Status • (See Co-Occurring Psychiatric Disorders) Laboratory • CBC, LFTs, HIV, hepatitis A, B & C • Urine drug testing (frequently) • STDs(?) • Pregnancy(?) Social and Environmental Factors Relapse prevention Switch medications Psychosocial treatment Pain (See Individuals with Pain) Buprenorphine a Methadone Naltrexone Level 1 Outpatient, general medical or addiction /WM Level 2 Specialty addiction intensive outpatient /WM Level 3 Residential /WM Level 4 Hospital /WM Select treatment site Identify and refer urgent problems Relapse Procedure 1. Change in treatment plan– focus on medication adherence 2. Consideration of intensity of care 3. Switch medications a Use combination product unless otherwise specified. • Clonidine • Other ancillary medications To address withdrawal symptoms, add: LEGEND Diagnosis/Evaluation Treatment Results, Notes, Status Important Comments

Articles in this issue

Archives of this issue

view archives of ASAM Provider Guide - National Practice Guideline